{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:20:11Z","timestamp":1761855611234,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.medcli.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T06:48:34Z","timestamp":1595659714000},"page":"473-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An\u00e1lisis de la relaci\u00f3n entre los inhibidores del sistema renina-angiotensina y la evoluci\u00f3n de pacientes hospitalizados por infecci\u00f3n respiratoria COVID-19"],"prefix":"10.1016","volume":"155","author":[{"given":"Jorge","family":"Mart\u00ednez-del R\u00edo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Piqueras-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Nieto-Sandoval Mart\u00edn de la Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Negreira-Caama\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"\u00c1guila-Gordo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mateo-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Salas-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rodr\u00edguez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.07.004_bib0150","article-title":"Cardiovascular manifestations and treatment considerations in covid-19","volume":"30","author":"Kang","year":"2020","journal-title":"Heart."},{"key":"10.1016\/j.medcli.2020.07.004_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0160","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.mayocp.2020.03.026","article-title":"Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease","volume":"95","author":"Sanchis-Gomar","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.medcli.2020.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensinII receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res."},{"key":"10.1016\/j.medcli.2020.07.004_bib0170","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0175","doi-asserted-by":"crossref","first-page":"e016219","DOI":"10.1161\/JAHA.120.016219","volume":"9","author":"Guo","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.medcli.2020.07.004_bib0180","first-page":"2020","article-title":"Cardiovascular disease, drug therapy, and mortality in Covid-19","volume":"1","author":"Mehra","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0185","doi-asserted-by":"crossref","first-page":"M406","DOI":"10.1136\/bmj.m406","article-title":"Response to the emerging novel coronavirus outbreak","volume":"368","author":"Kickbusch","year":"2020","journal-title":"BMJ."},{"key":"10.1016\/j.medcli.2020.07.004_bib0190","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","article-title":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","volume":"38","author":"Esler","year":"2020","journal-title":"J Hypertens."},{"key":"10.1016\/j.medcli.2020.07.004_bib0200","article-title":"Preventing a COVID-19 pandemic: ACE inhibitors as a potential risk factor for fatal COVID-19","volume":"368","author":"Sommerstein","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2020.07.004_bib0205","first-page":"1","article-title":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis","volume":"2020","author":"Wang","year":"2020","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.medcli.2020.07.004_bib0210","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.medcli.2020.07.004_bib0215","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.07.004_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pupt.2017.05.002","article-title":"Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2\/STATs and apoptosis in rat","volume":"45","author":"Li","year":"2017","journal-title":"Pulm Pharmacol Ther."},{"key":"10.1016\/j.medcli.2020.07.004_bib0225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/SHK.0b013e3180310f3a","article-title":"Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats","volume":"28","author":"He","year":"2007","journal-title":"Shock."},{"key":"10.1016\/j.medcli.2020.07.004_bib0230","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: A single-center retrospective study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.medcli.2020.07.004_bib0240","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0245","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.recesp.2020.03.014","article-title":"Controversias sobre el tratamiento con IECA\/ARA-II y Covid-19","volume":"73","author":"Arcos","year":"2020","journal-title":"Rev Esp Cardiol."},{"unstructured":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers [nota de prensa]. Marzo 2020.","key":"10.1016\/j.medcli.2020.07.004_bib0250"},{"unstructured":"A statement from the International Society of Hypertension on COVID-19 [nota de prensa]. Marzo 2020.","key":"10.1016\/j.medcli.2020.07.004_bib0255"},{"unstructured":"Situaci\u00f3n de COVID-19 en Espa\u00f1a. Ministerio de Sanidad. https:\/\/covid19.isciii.es\/","key":"10.1016\/j.medcli.2020.07.004_bib0260"},{"key":"10.1016\/j.medcli.2020.07.004_bib0265","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.recesp.2015.11.036","article-title":"Prevalencia, diagn\u00f3stico, tratamiento y control de la hipertensi\u00f3n arterial en Espa\u00f1a. Resultados del estudio Di@bet.es","volume":"69","author":"Men\u00e9ndez","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.medcli.2020.07.004_bib0270","doi-asserted-by":"crossref","first-page":"2166-2171","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xudong","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.medcli.2020.07.004_bib0275","doi-asserted-by":"crossref","first-page":"e0213096","DOI":"10.1371\/journal.pone.0213096","article-title":"Circulating angiotensin peptides levels in acute respiratory distress syndrome correlate with clinical outcomes: A pilot study","volume":"14","author":"Reddy","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2020.07.004_bib0280","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: A case-population study","volume":"395","author":"Abajo","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2020.07.004_bib0285","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","author":"Mancia","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.07.004_bib0290","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320304802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320304802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:51:29Z","timestamp":1758419489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320304802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0025775320304802"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.07.004","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An\u00e1lisis de la relaci\u00f3n entre los inhibidores del sistema renina-angiotensina y la evoluci\u00f3n de pacientes hospitalizados por infecci\u00f3n respiratoria COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}